ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,509.01
0.62%
US Tech 100
19,460.00
0.95%
Dow Jones
39,331.85
0.41%
Brent Oil
86.565
0.14%
Bitcoin
60,859.42
-1.88%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) News

AZTR

Azitra (AZTR)

Azitra Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AZTR
DateTimeSourceHeadlineSymbolCompany
06/27/20244:05PMBusiness WireAzitra, Inc. Announces Reverse Stock SplitAMEX:AZTRAzitra Inc
06/03/20244:30PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AZTRAzitra Inc
05/31/20248:00AMBusiness WireAzitra, Inc. Announces Presentation at the 2024 BIO International ConventionAMEX:AZTRAzitra Inc
05/24/20244:55PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AZTRAzitra Inc
05/17/20248:00AMBusiness WireAzitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual MeetingAMEX:AZTRAzitra Inc
05/10/20248:00AMBusiness WireAzitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual MeetingAMEX:AZTRAzitra Inc
05/09/20245:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
05/09/20245:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
05/09/20245:00PMBusiness WireAzitra, Inc. Announces Q1 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
04/22/20244:30PMBusiness WireAzitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy MeetingAMEX:AZTRAzitra Inc
04/18/20244:15PMBusiness WireAzitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024AMEX:AZTRAzitra Inc
03/15/20244:15PMBusiness WireAzitra, Inc. Announces Full Year 2023 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
02/26/20244:10PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:AZTRAzitra Inc
02/26/20244:05PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:AZTRAzitra Inc
02/16/20244:05PMBusiness WireAzitra, Inc. Announces Closing of Public OfferingAMEX:AZTRAzitra Inc
02/15/20248:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
02/15/20248:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
02/15/20248:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
02/15/20244:44PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AZTRAzitra Inc
02/14/20249:15AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
02/13/202410:09PMBusiness WireAzitra, Inc. Announces Pricing of Public OfferingAMEX:AZTRAzitra Inc
01/19/202411:08AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:AZTRAzitra Inc
01/19/20249:19AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AZTRAzitra Inc
01/16/20249:00AMBusiness WireAzitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the USAMEX:AZTRAzitra Inc
01/03/20249:00AMBusiness WireAzitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare ConferenceAMEX:AZTRAzitra Inc
12/04/20234:06PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AZTRAzitra Inc
11/14/20234:30PMBusiness WireAzitra, Inc. Announces Third Quarter 2023 Financial Results and Business UpdatesAMEX:AZTRAzitra Inc
10/16/20238:00AMBusiness WireAzitra to Present at the ThinkEquity ConferenceAMEX:AZTRAzitra Inc
10/03/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
10/03/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
 Showing the most relevant articles for your search:AMEX:AZTR

Your Recent History

USOTC
NNAX
New Momentum (PK)
NASDAQ
TSLA
Tesla
USOTC
ASKH
Astika (PK)
USOTC
CNNA
Cann American (CE)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
PHIL
PHI (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RNVA
Rennova Health (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
AXXA
Exxe (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
RXMD
Progressive Care (QB)
USOTC
GGSM
Gold and GemStone Mining (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved